Company Filing History:
2 out of 28,566 
2 out of 6,070 
Years Active: 2022-2023
Title: Yu Teshima: Innovator in Diagnosis Technology
Introduction
Yu Teshima is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of diagnosis technology, holding a total of 2 patents. His work focuses on developing advanced systems that enhance the efficiency and accuracy of diagnostic processes.
Latest Patents
Yu Teshima's latest patents include innovative devices and systems designed for diagnosis. One of his patents describes a diagnosis device that comprises a first acquisition unit, a second acquisition unit, and an associating unit. The first acquisition unit is responsible for acquiring context information from a machine tool, which includes a monitoring specifying number that identifies a machining process. The second acquisition unit collects detection information from a detection unit installed on the machine tool. The associating unit then correlates the monitoring specifying number with the detection information. Another patent outlines a diagnosis device that includes a first acquiring unit for context information, a second acquiring unit for detection information, and various units for extracting, selecting, calculating, determining, and estimating process intervals based on the acquired data.
Career Highlights
Throughout his career, Yu Teshima has worked with prominent companies such as Ricoh Company, Ltd. and Fanuc Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in diagnosis technology.
Collaborations
Yu Teshima has collaborated with notable colleagues, including Yasuhiro Nakahama and Satoru Goto. These partnerships have fostered a creative environment that has led to the development of advanced diagnostic solutions.
Conclusion
Yu Teshima is a distinguished inventor whose work in diagnosis technology has made a significant impact in the field. His innovative patents and collaborations with industry leaders highlight his commitment to advancing diagnostic processes.